Sandoz Group AG

Sandoz Group AG is a Swiss-based pharmaceutical company specializing in the development, manufacturing, and distribution of generic pharmaceuticals and biosimilars. With a legacy dating back to 1886, Sandoz is recognized as a global leader in its sector, providing cost-effective alternatives to branded medicines and thereby expanding patient access to vital treatments. The company's core operations cover a wide array of therapeutic areas, fulfilling a crucial role in supporting healthcare systems worldwide by delivering approximately 80% of global medicines through generics and biosimilars. Sandoz serves a broad network including wholesalers, hospitals, pharmacies, and other healthcare providers, reinforcing its pivotal role in both mature and emerging markets. In recent years, Sandoz has operated independently following its spin-off from Novartis, and continues to drive innovation in healthcare through pioneering agreements and acquisitions. Its impact on the pharmaceutical landscape lies in enhancing medical accessibility and affordability on a global scale.